{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:52:07Z","timestamp":1786996327609,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rmed.2024.107840","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T13:07:53Z","timestamp":1730293673000},"page":"107840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Perception and participation in sport and exercise in cystic fibrosis: The impact of CFTR modulators"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9544-4420","authenticated-orcid":false,"given":"Akos","family":"Berthold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-4680","authenticated-orcid":false,"given":"Eileen","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-1201","authenticated-orcid":false,"given":"Lauren","family":"Lichten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1882-7132","authenticated-orcid":false,"given":"William R.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmed.2024.107840_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.rmed.2024.107840_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/17476348.2014.966693","article-title":"Cystic fibrosis and physiological responses to exercise","volume":"8","author":"Williams","year":"2014","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmed.2024.107840_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fphys.2019.01382","article-title":"Exercise Physiology across the lifespan in cystic fibrosis","volume":"10","author":"Shei","year":"2019","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.rmed.2024.107840_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4187\/respcare.07193","article-title":"Physical activity level and perception of exercise in cystic fibrosis","volume":"65","author":"Burnett","year":"2020","journal-title":"Respir. Care"},{"issue":"11","key":"10.1016\/j.rmed.2024.107840_bib5","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/ppul.25041","article-title":"Physical exercise as a tool to minimize the consequences of the Covid-19 quarantine: an overview for cystic fibrosis","volume":"55","author":"Fernandez-Del-Valle","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.rmed.2024.107840_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12890-021-01482-x","article-title":"Factors influencing physical activity in adults with cystic fibrosis","volume":"21","author":"Hurley","year":"2021","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.rmed.2024.107840_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00294-2019","article-title":"Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals","volume":"6","author":"Denford","year":"2020","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.rmed.2024.107840_bib8","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1038\/s41598-019-43652-2","article-title":"A systematic review of the clinical efficacy and safety of CFTR modulators in cystic fibrosis","volume":"9","author":"Habib","year":"2019","journal-title":"Sci. Rep."},{"issue":"10212","key":"10.1016\/j.rmed.2024.107840_bib9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2024.107840_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.rmed.2024.107840_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092829","article-title":"Validity of electronically administered recent physical activity questionnaire (RPAQ) in ten European countries","volume":"9","author":"Golubic","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.rmed.2024.107840_bib12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"Compendium of Physical Activities: a second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med. Sci. Sports Exerc."},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2024.107840_bib13","first-page":"S40","article-title":"Overweight and cystic fibrosis: an unexpected challenge","volume":"57","author":"Gabel","year":"2022","journal-title":"Pediatr. Pulmonol."},{"issue":"2","key":"10.1016\/j.rmed.2024.107840_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.rmed.2024.107840_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.rmed.2024.107840_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2024.107840_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2017.05.008","article-title":"Worsening anxiety and depression after initiation of lumacaftor\/ivacaftor combination therapy in adolescent females with cystic fibrosis","volume":"16","author":"McKinzie","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2024.107840_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.psym.2017.04.001","article-title":"Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis","volume":"58","author":"Talwalkar","year":"2017","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.rmed.2024.107840_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of Elexacaftor\/Tezacaftor\/Ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2024.107840_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther. Adv. Respir. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:37:27Z","timestamp":1735655847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124003159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"alternative-id":["S0954611124003159"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107840","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perception and participation in sport and exercise in cystic fibrosis: The impact of CFTR modulators","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107840"}}